Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $2.3 million.

  • Zevra Therapeutics' Interest & Investment Income rose 12049.57% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 10996.75%. This contributed to the annual value of $2.2 million for FY2024, which is 5210.31% down from last year.
  • As of Q3 2025, Zevra Therapeutics' Interest & Investment Income stood at $2.3 million, which was up 12049.57% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Interest & Investment Income registered a high of $2.4 million during Q2 2025, and its lowest value of -$73000.0 during Q4 2024.
  • Over the past 5 years, Zevra Therapeutics' median Interest & Investment Income value was $278000.0 (recorded in 2022), while the average stood at $733421.1.
  • In the last 5 years, Zevra Therapeutics' Interest & Investment Income skyrocketed by 1253333.33% in 2022 and then plummeted by 13476.19% in 2024.
  • Zevra Therapeutics' Interest & Investment Income (Quarter) stood at $125000.0 in 2021, then skyrocketed by 122.4% to $278000.0 in 2022, then dropped by 24.46% to $210000.0 in 2023, then tumbled by 134.76% to -$73000.0 in 2024, then surged by 3268.49% to $2.3 million in 2025.
  • Its Interest & Investment Income stands at $2.3 million for Q3 2025, versus $2.4 million for Q2 2025 and $543000.0 for Q1 2025.